Implication of miRNA-153 on PTEN expression in prostatic adenocarcinoma

Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):6834-6843. doi: 10.26355/eurrev_202111_27231.

Abstract

Objective: A little is known about the role of miRNA-153 expression in prostate cancer (PCa), in this study we aimed to determine the prognostic value of miRNA-153 and PTEN expression in PCa, by correlating their expression with Gleason patterns, Gleason scores, and Grade groups.

Patients and methods: In situ hybridization for miRNA-153 and immunohistochemical staining for PTEN were applied on microarray sections of 80 PCa, with different Gleason grades, and 20 benign prostate hyperplasia (BPH) cases.

Results: We found that miRNA-153 expression was significantly higher and PTEN was significantly lower in PCa compared to BPH. In PCa, high miRNA-153 expression and loss of PTEN expression were associated significantly with higher Gleason patterns, higher Gleason scores, and higher Grade groups. The expression of miRNA-153 showed a significant inverse correlation with PTEN expression.

Conclusions: Increased miRNA-153 expression and lost PTEN expression in PCa may provide information on their role in the progression of this cancer, suggesting that miRNA-153 could affect PTEN directly in prostatic neoplastic and hyperplastic lesions, and therefore miRNA-153 can be considered a new tool to improve the treatment efficacy and prognosis of PCa patients.

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology
  • Aged
  • Humans
  • Male
  • MicroRNAs*
  • Middle Aged
  • PTEN Phosphohydrolase / metabolism*
  • Prognosis
  • Prostate / metabolism
  • Prostate / pathology
  • Prostatic Hyperplasia / genetics
  • Prostatic Hyperplasia / metabolism
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology

Substances

  • MIRN153 microRNA, human
  • MicroRNAs
  • PTEN Phosphohydrolase
  • PTEN protein, human